Filing Details

Accession Number:
0001638599-16-001094
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-17 16:01:55
Reporting Period:
2016-06-01
Filing Date:
2016-06-17
Accepted Time:
2016-06-17 16:01:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1429260 Fortress Biotech Inc. FBIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
941841 Md A Lindsay Rosenwald C/o Fortress Biotech, Inc.
2 Gansevoort Street, 9Th Floor
New York NY 10014
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2016-06-01 613 $2.40 5,303,739 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.001 170,983 Indirect By Capretti Grandi LLC
Common Stock, Par Value $0.001 453,822 Indirect By LAR Family Trusts
Common Stock, Par Value $0.001 742,861 Indirect By Paramount Biosciences
Common Stock, Par Value $0.001 100,000 Indirect By The Lindsay A. Rosenwald Rhode Island Irrevocable Trust U/T/A DTD 8-28-01
Common Stock, Par Value $0.001 80,000 Indirect By The Lindsay A. Rosenwald Alaska Irrevocable Trust U/T/A DTD 8-29-01
Common Stock, Par Value $0.001 720,000 Indirect By The Lindsay A. Rosenwald 2000 Irrevocable Trust U/T/A DTD 5-24-00
Common Stock, Par Value $0.001 100,000 Indirect By The Lindsay A. Rosenwald Nevada Irrevocable Indenture of Trust U/T/A DTD 8-29-01
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Options to purchase Common Stock $1.37 2020-10-05 25,000 25,000 Direct
Common Stock Options to purchase Common Stock $6.25 2022-02-10 15,000 15,000 Direct
Common Stock Options to purchase Common Stock $7.42 2023-02-07 15,000 15,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2020-10-05 25,000 25,000 Direct
2022-02-10 15,000 15,000 Direct
2023-02-07 15,000 15,000 Direct
Footnotes
  1. These shares were acquired under the Issuer's 2012 Employee Stock Purchase Plan.
  2. This option is fully vested.
  3. One-third of the shares vested on each of February 10, 2013, 2014 and 2015.
  4. One-third of the shares vested on each of February 7, 2014, 2015 and 2016.